SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-027398
Filing Date
2018-10-24
Accepted
2018-10-24 17:57:16
Documents
2
Period of Report
2018-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1627
2 EX-24 DOCUMENT attachment1.htm EX-24 4100
  Complete submission text file 0000899243-18-027398.txt   7160
Mailing Address C/O SOLIGENIX, INC. 29 EMMONS DRIVE, STE. C-10 PRINCETON NJ 08540
Business Address
HORGAN KEVIN (Reporting) CIK: 0001510614 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 181137230

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations